NewsBenzinga에박시온, 진행성 흑색종 환자 대상 EVX-의 2상 연구 데이터 발표···유도된 면역 반응 및 예측 성능 강조 에박시온, 진행성 흑색종 환자 대상 EVX-의 2상 연구 데이터 발표···유도된 면역 반응 및 예측 성능 강조 Benzinga 2026.11.06 16:05 (GMT+0) Open on Benzinga Other news Truist Securities Reiterates Buy on Magnolia Oil & Gas, Raises Price Target to $37 RBC Capital Maintains Outperform on Doximity, Raises Price Target to $34 Why Is D-Wave Quantum Stock Surging on Friday? Truist Securities Maintains Buy on MACOM Technology Solns, Lowers Price Target to $310 Scotiabank Maintains Sector Outperform on Black Hills, Raises Price Target to $95 OpenAI Announces Partnering With Hacktron To Find Vulnerabilities In OpenAI’s Systems
